Methyl 3-(1,2,3,4-tetrahydroisoquinolin-6-yl)propanoate hydrochloride, 97%, 100mg

Ricevitore per vuoto con attacco filettato curvo 105°, 29/32, 29/32, 1 Pezzo

6-CHLORO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-2-CARBOXYLIC ACID, 97.0%, 250mg

Methyl 6-bromo-3-chloro-2-fluorobenzoate, 95.0%, 250mg

1,3-Pentadiene (cis- and trans- mixture) (stabilized with TBC)>96.0%(GC)25mL

5-Methyl-1,3,4-oxadiazol-2(3H)-one, 95.0%, 1g

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea, 98%, 25mg

Potassium Trihydrogen Dioxalate Dihydrate>99.0%(T)500g

2,2'-(Ethane-1,2-diyl)bis(4,5,6,7-tetrabromoisoindoline-1,3-dione), 98%, 250g

Methyl (2S,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride, 97.0%, 25g

2-Amino-5-bromo-4-chloro-3-nitropyridine, 95.0%, 25g

(2S,4S)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID DIHYDROCHLORIDE, 95.0%, 100mg

N-[3-(1H-imidazol-1-yl)propyl]-5,7-dimethyl-1,3-benzothiazol-2-amine, 95.0%, 250mg